Cargando…
Using Nuclear Receptor Activity to Stratify Hepatocarcinogens
BACKGROUND: Nuclear receptors (NR) are a superfamily of ligand-activated transcription factors that control a range of cellular processes. Persistent stimulation of some NR is a non-genotoxic mechanism of rodent liver cancer with unclear relevance to humans. Here we report on a systematic analysis o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038857/ https://www.ncbi.nlm.nih.gov/pubmed/21339822 http://dx.doi.org/10.1371/journal.pone.0014584 |
_version_ | 1782198129428267008 |
---|---|
author | Shah, Imran Houck, Keith Judson, Richard S. Kavlock, Robert J. Martin, Matthew T. Reif, David M. Wambaugh, John Dix, David J. |
author_facet | Shah, Imran Houck, Keith Judson, Richard S. Kavlock, Robert J. Martin, Matthew T. Reif, David M. Wambaugh, John Dix, David J. |
author_sort | Shah, Imran |
collection | PubMed |
description | BACKGROUND: Nuclear receptors (NR) are a superfamily of ligand-activated transcription factors that control a range of cellular processes. Persistent stimulation of some NR is a non-genotoxic mechanism of rodent liver cancer with unclear relevance to humans. Here we report on a systematic analysis of new in vitro human NR activity data on 309 environmental chemicals in relationship to their liver cancer-related chronic outcomes in rodents. RESULTS: The effects of 309 environmental chemicals on human constitutive androstane receptors (CAR/NR1I3), pregnane X receptor (PXR/NR1I2), aryl hydrocarbon receptor (AhR), peroxisome proliferator-activated receptors (PPAR/NR1C), liver X receptors (LXR/NR1H), retinoic X receptors (RXR/NR2B) and steroid receptors (SR/NR3) were determined using in vitro data. Hepatic histopathology, observed in rodents after two years of chronic treatment for 171 of the 309 chemicals, was summarized by a cancer lesion progression grade. Chemicals that caused proliferative liver lesions in both rat and mouse were generally more active for the human receptors, relative to the compounds that only affected one rodent species, and these changes were significant for PPAR (p[Image: see text]0.001), PXR (p[Image: see text]0.01) and CAR (p[Image: see text]0.05). Though most chemicals exhibited receptor promiscuity, multivariate analysis clustered them into relatively few NR activity combinations. The human NR activity pattern of chemicals weakly associated with the severity of rodent liver cancer lesion progression (p[Image: see text]0.05). CONCLUSIONS: The rodent carcinogens had higher in vitro potency for human NR relative to non-carcinogens. Structurally diverse chemicals with similar NR promiscuity patterns weakly associated with the severity of rodent liver cancer progression. While these results do not prove the role of NR activation in human liver cancer, they do have implications for nuclear receptor chemical biology and provide insights into putative toxicity pathways. More importantly, these findings suggest the utility of in vitro assays for stratifying environmental contaminants based on a combination of human bioactivity and rodent toxicity. |
format | Text |
id | pubmed-3038857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30388572011-02-18 Using Nuclear Receptor Activity to Stratify Hepatocarcinogens Shah, Imran Houck, Keith Judson, Richard S. Kavlock, Robert J. Martin, Matthew T. Reif, David M. Wambaugh, John Dix, David J. PLoS One Research Article BACKGROUND: Nuclear receptors (NR) are a superfamily of ligand-activated transcription factors that control a range of cellular processes. Persistent stimulation of some NR is a non-genotoxic mechanism of rodent liver cancer with unclear relevance to humans. Here we report on a systematic analysis of new in vitro human NR activity data on 309 environmental chemicals in relationship to their liver cancer-related chronic outcomes in rodents. RESULTS: The effects of 309 environmental chemicals on human constitutive androstane receptors (CAR/NR1I3), pregnane X receptor (PXR/NR1I2), aryl hydrocarbon receptor (AhR), peroxisome proliferator-activated receptors (PPAR/NR1C), liver X receptors (LXR/NR1H), retinoic X receptors (RXR/NR2B) and steroid receptors (SR/NR3) were determined using in vitro data. Hepatic histopathology, observed in rodents after two years of chronic treatment for 171 of the 309 chemicals, was summarized by a cancer lesion progression grade. Chemicals that caused proliferative liver lesions in both rat and mouse were generally more active for the human receptors, relative to the compounds that only affected one rodent species, and these changes were significant for PPAR (p[Image: see text]0.001), PXR (p[Image: see text]0.01) and CAR (p[Image: see text]0.05). Though most chemicals exhibited receptor promiscuity, multivariate analysis clustered them into relatively few NR activity combinations. The human NR activity pattern of chemicals weakly associated with the severity of rodent liver cancer lesion progression (p[Image: see text]0.05). CONCLUSIONS: The rodent carcinogens had higher in vitro potency for human NR relative to non-carcinogens. Structurally diverse chemicals with similar NR promiscuity patterns weakly associated with the severity of rodent liver cancer progression. While these results do not prove the role of NR activation in human liver cancer, they do have implications for nuclear receptor chemical biology and provide insights into putative toxicity pathways. More importantly, these findings suggest the utility of in vitro assays for stratifying environmental contaminants based on a combination of human bioactivity and rodent toxicity. Public Library of Science 2011-02-14 /pmc/articles/PMC3038857/ /pubmed/21339822 http://dx.doi.org/10.1371/journal.pone.0014584 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Shah, Imran Houck, Keith Judson, Richard S. Kavlock, Robert J. Martin, Matthew T. Reif, David M. Wambaugh, John Dix, David J. Using Nuclear Receptor Activity to Stratify Hepatocarcinogens |
title | Using Nuclear Receptor Activity to Stratify Hepatocarcinogens |
title_full | Using Nuclear Receptor Activity to Stratify Hepatocarcinogens |
title_fullStr | Using Nuclear Receptor Activity to Stratify Hepatocarcinogens |
title_full_unstemmed | Using Nuclear Receptor Activity to Stratify Hepatocarcinogens |
title_short | Using Nuclear Receptor Activity to Stratify Hepatocarcinogens |
title_sort | using nuclear receptor activity to stratify hepatocarcinogens |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038857/ https://www.ncbi.nlm.nih.gov/pubmed/21339822 http://dx.doi.org/10.1371/journal.pone.0014584 |
work_keys_str_mv | AT shahimran usingnuclearreceptoractivitytostratifyhepatocarcinogens AT houckkeith usingnuclearreceptoractivitytostratifyhepatocarcinogens AT judsonrichards usingnuclearreceptoractivitytostratifyhepatocarcinogens AT kavlockrobertj usingnuclearreceptoractivitytostratifyhepatocarcinogens AT martinmatthewt usingnuclearreceptoractivitytostratifyhepatocarcinogens AT reifdavidm usingnuclearreceptoractivitytostratifyhepatocarcinogens AT wambaughjohn usingnuclearreceptoractivitytostratifyhepatocarcinogens AT dixdavidj usingnuclearreceptoractivitytostratifyhepatocarcinogens |